A noninvasive biomarker-based test could help shorten the diagnostic delay for endometriosis. The most investigated biomarker sources are peripheral blood and endometrium. Discovery of endometriosis biomarkers is often hypothesis-driven, i.e. when one or a few biomarkers are investigated based on their role in the disease pathogenesis. Alternatively, a hypothesis-generating approach has been followed using the "omics" technologies. A variety of biomarkers for endometriosis have been investigated, but no biomarker has been validated for clinical use. Many challenges lie ahead in the endometriosis biomarker field. In the future, harmonized collection and reporting methods should allow large-scale international collaboration for highly powered studies.
Noninvasive diagnosis of endometriosis: Review of current peripheral blood and endometrial biomarkers.
D. O,Idhaliz Flores,E. Waelkens,T. D’Hooghe
Published 2018 in Best Practice & Research: Clinical Obstetrics & Gynaecology
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Best Practice & Research: Clinical Obstetrics & Gynaecology
- Publication date
2018-07-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-80 of 80 references · Page 1 of 1
CITED BY
Showing 1-46 of 46 citing papers · Page 1 of 1